ASHLEY SCOFIELD: Open Payments
NPI 1770137689 · SYRACUSE, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$870 in 40 payments from 11 companies in 2025. Trend: 2023 $550 · 2024 $730 · 2025 $870
Food & beverage: $785Education: $85
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 9 | $268 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $107 |
| Biogen, Inc. | 6 | $101 |
| SHIELD THERAPEUTICS INC | 6 | $94 |
| MAYNE PHARMA COMMERCIAL LLC | 4 | $93 |
| PFIZER INC. | 4 | $67 |
| Sumitomo Pharma America, Inc. | 2 | $35 |
| MILLICENT US INC | 1 | $33 |
| ABBVIE INC. | 1 | $31 |
| Organon LLC | 1 | $26 |
Products named: Veozah, ZURZUVAE, ACCRUFER, ABRYSVO, Mirena, Lynkuet, MYFEMBREE, INTRAROSA.
Industry payments across NY — which companies pay providers there.
